No takes yet. Share an insight, caveat, or question.
Preclinical study reveals attenuated gastrointestinal acute graft-versus-host disease in IL-12Rβ2-deficient mice, indicating nonhematopoietic receptors as potential therapeutic targets.
Bastian et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: